Kinetin license
This article was originally published in The Rose Sheet
Executive Summary
Global non-exclusive licensing agreement between Senetek and Danish health care company Ferrosan will result in expanded mass market distribution of Senetek's Kinetin anti-aging technology, firm says. Ferrosan plans to market a line of skin care products with Kinetin under its Imedeen brand of oral skin care supplements, according to the company. Under the agreement, Ferrosan will manufacture and market the range in the mass market, as well as prestige, natural product and direct-to-consumer channels globally. Senetek recently amended a licensing agreement with Revlon that gave the cosmetics firm exclusive use of Kinetin in the mass market; the ingredient is used in Revlon's Almay Kinetin line, which bowed in 2001 (1"The Rose Sheet" March 19, 2001, p. 7)...
You may also be interested in...
Almay Kinetin Anti-Aging Launch Marks Ingredient's Mass Debut
Almay expects its new Kinetin Skincare Advanced Anti-Aging Series will attract department store shoppers to the mass brand, Exec VP and General Manager Vanessa Solomon said. Slated to launch globally in June, the seven-SKU line will be the first skin care offering in the U.S. mass market to contain the antioxidant ingredient.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.